NCT00213538View on ClinicalTrials.gov

Gene Expression Profiling in PBMCs as a Tool for Prediction of Anakinra Responsiveness in Rheumatoid Arthritis

CompletedOBSERVATIONAL

Enrollment

341

Participants

Timeline

Start Date

June 30, 2003

Primary Completion Date

December 31, 2016

Study Completion Date

December 31, 2016

Conditions

Rheumatoid Arthritis

Interventions

DRUG

Response to anakinra associated with methotrexate

Trial Locations (1)

76031

CHU de rouen - Hôpitaux de Rouen, Rouen

All Listed Sponsors

lead

University Hospital, Rouen

OTHER

NCT00213538 - Gene Expression Profiling in PBMCs as a Tool for Prediction of Anakinra Responsiveness in Rheumatoid Arthritis | Biotech Hunter | Biotech Hunter